Ionis Pharmaceuticals reported 396.15 in PE Price to Earnings for its fiscal quarter ending in September of 2022.





Pe Change Date
Agios Pharmaceuticals 3.56 0.68 Sep/2025
Alnylam Pharmaceuticals 170.7 367.33 Dec/2025
Astellas Pharma 7.31 2.04 Dec/2025
BioCryst Pharmaceuticals 6.06 1.07K Dec/2025
BioMarin Pharmaceutical 19.24 0.21 Dec/2025
Celltrion 50.09 23.24 Sep/2025
Cspc Pharmaceutical 25.53 3.8 Sep/2025
Deva Holding AS 6.55 2.01 Sep/2023
Divis Laboratories Ltd 66.5 5.69 Dec/2025
Esperion Therapeutics 129.79 129 Dec/2024
Exelixis 602.31 586.25 Dec/2025
Halozyme Therapeutics 23.16 7.7 Dec/2025
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
Kangmei Pharma 3.15K 624.19 Jun/2025
Knight Therapeutics 257.34 166.24 Dec/2025
Laboratorios Farma 18.78 6.64 Dec/2023
Malin Corporation 11.81 0.72 Jun/2023
Moderna 27.22 14.51 Jun/2023
Neuren Pharmaceuticals 72.14 59.86 Dec/2025
Neurocrine Biosciences 835.47 802.2 Dec/2025
Novartis 17.85 2.11 Dec/2025
OPKO Health 40.77 7.86 Sep/2021
Organigram Holdings 235 224.49 Sep/2025
Ovoca Bio 1.83 3.29 Jun/2024
Pfizer 14.48 5.18 Dec/2025
Pharma Mar 17.41 29.74 Dec/2025
PTC Therapeutics 9.98 3.25 Dec/2025
Qiagen NV 20.54 0.1 Dec/2025
Regeneron Pharmaceuticals 18.11 2.91 Dec/2025
Roche Holding 16.09 3.51 Dec/2025
Sarepta Therapeutics 27.27 0 Sep/2025
Sartorius 34.42 122.1 Sep/2025
Sino Biopharmaceutical 17.03 0.89 Jun/2025
Tilray 11.56 80.19 Sep/2025
Vertex Pharmaceuticals 26.15 2.22 Dec/2025
Zealand Pharma A/S 5.13 0.16 Dec/2025
Zz Pientze Pharmaceu 49.04 4.33 Sep/2025